La Capitale Financial Security Long Term Care Insurance Height and Weight Guide
The fol owing height and weight table applies to males and females. The weight of a proposed insured must have remained stable for a period of 12 months prior to the application. If the applicant falls outside the range listed below, they are not insurable with La Capitale Financial Security.
English system Metric system Height Weight Height Weight (in feet) (in pounds) (in centimetres) (in kilograms) 4’10’’ 4’11’’ 5’0’’ 5’1’’ 5’2’’ 5’3’’ 5’4’’ 5’5’’ 5’6’’ 5’7’’ 5’8’’ 5’9’’ 5’10’’ 5’11’’ 6’0’’ 6’1’’ 6’2’’ 6’3’’ 6’4’’ 6’5’’ 6’6’’ La Capitale Financial Security Insurance Company 7150 Derrycrest Dr, Mississauga ON L5W 0E5 Page 1 of 2 Guide to Medication
Any medication (prescription or over-the-counter drugs) taken by the proposed insured is important and must be indicated on the application. If the medication is for high blood pressure (and only 1 is listed) indicate on the application how often a doctor monitors. Lack of follow up by MD or too frequent visits indicating lack of control may require a La Capitale Financial Security application. Below is a list of some drugs associated with health problems that wil be rejected by La Capitale Financial Security underwriters – if applying to La Capitale Financial Security refer to the La Capitale Financial Security Field Guide. Eldepryl Lasix >80 mg/day Parlodel Adriamycin Percocet Ergamisol Laradopa Permitil Akineton Ergoloid Platinol Leukeran Pramipexole Prednisone Thioplex Antibuse Levadopa >6 mg/day Thorazine Timespan Loxitane Procyclidine Arimidex Lioresal Trelstar Foscavir Lysodren Proleukin Trihexane Prostigmin Trilafon Baclofen Matulane Purinethol Benztropine Galantamine Prolixin Mellaril Blenoxane Razadyne Bromocriptine Mesoridazine Rebetron Busulfex/Busulfan Gold Therapy Mestinon Methadone Remicade Methotrexate Wellcovorin Haloperidol Wellferon Carbidopa Herceptin Risperidone Retrovir Hydergine Molindone Cerefolin Mitomycin/Mutamycin Risperidil Cerubidine Clozaril Rivastigmine Cogentin Natrecor Cytosar-U Interferon Neupogen Serentil Seroquel Dacarbazine Kemadrin Nilandron Stelazine Donepezil Nitroglycerin Symadine Novantrone Symmetrel Dostinex Oxycodone OxyContin La Capitale Financial Security Insurance Company 7150 Derrycrest Dr, Mississauga ON L5W 0E5 Page 2 of 2
Excerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION The study of the absorption, distribution, metabolism and excretion of drugs is referred to as pharmacokinetics . The study of the absorption, distribution, metabolism and excretion of nutrients is nutrient kinetics . Absorption: Process by which a d
A 43-year-old man developed bilateral painless visionloss with photophobia, photopsia, and nyctalopia overseveral weeks. He had undergone allogeneic bone marrow1. Strouthidis NG, Francis PJ, Stanford MR, et al. Posterior seg-transplant 10 years earlier for aplastic anemia. He subse-ment complications of graft versus host disease after bone marrowtransplantation. Br J Ophthalmol 2003;87:1421–
La Capitale Financial Security Long Term Care Insurance 
Guide to Medication